Top

Gepubliceerd in:

01-08-2013

Type D, anxiety and depression in association with quality of life in patients with Parkinson’s disease and patients with multiple sclerosis

Auteurs: Tatiana Dubayova, Martina Krokavcova, Iveta Nagyova, Jaroslav Rosenberger, Zuzana Gdovinova, Berrie Middel, Johan W. Groothoff, Jitse P. van Dijk

Gepubliceerd in: Quality of Life Research | Uitgave 6/2013

Abstract

Purpose

The present study examines the role of Type D personality, anxiety and depression in quality of life (QoL) in patients with two chronic neurological diseases—Parkinson’s disease (PD) and multiple sclerosis (MS).

Methods

This cross-sectional study included 142 PD patients (73 % males; mean age 67.6 ± 9.2 years) and 198 patients with MS (32.3 % males; 38.4 ± 10.8 years). Multiple regression analyses were used to analyze the association of UDPRS (PD patients) or EDSS (MS patients), Type D personality (DS-14) and anxiety and depression (HADS) with the physical (PCS) and mental summary (MCS) of QoL, as measured by the SF-36.

Results

In PD patients, Type D was significantly associated with MCS only; in MS patients, Type D was significantly associated with both dimensions—MCS and PCS. After adding anxiety and depression, the importance of Type D for the QoL model dramatically decreased. Anxiety and depression were strongly associated with lower scores in MCS and PCS in both PD and MS patients.

Conclusions

The actual mood of PD and MS patients—the level of anxiety or depression—might have a greater impact on patients’ QoL than their personality. Further longitudinal research should focus on how the pathway consisting of personality traits, anxiety and depression, and QoL might be constructed.

vorige artikel Multilevel socioeconomic effects on quality of life in adolescent and young adult survivors of leukemia and lymphoma

volgende artikel Health-related quality of life in the aftermath of child maltreatment: follow-up study of a hospital sample

Roth, J., Sekyrova, M., & Ruzicka, E. (1999). Parkinsonova nemoc [Parkinson’s disease] (2nd ed.). Praha: Maxdorf.

Simons, G., Thompson, S. B., & Smith-Pasqualini, M. C. (2006). An innovative education program for people with Parkinson’s disease and their carers. Parkinsonism and Related Disorders, 12(8), 478–485.PubMedCrossRef

European Commission. (2004). Some elements on the situation of multiple sclerosis in the European Union, 2004. http://ec.europa.eu/health/ph_information/dissemination/diseases/neuro_1.pdf. Access January 3, 2012.

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, P.-H., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50(1), 121–127.PubMedCrossRef

Bashir, K., & Whitaker, J. N. (2002). Handbook of multiple sclerosis. Philadelphia: Lipinncott Williams and Wilkins.

Damiano, A. M., Snyder, C., Strausser, B., & Willian, M. K. (1999). A review of health-related quality of life concepts and measures for Parkinson’s disease. Quality of Life Research, 8(3), 235–243.PubMedCrossRef

Schrag, A., Jahanshahi, M., & Quinn, N. (2000). How does Parkinson’s disease affects quality of life? A comparison with quality of life in general population. Movement Disorders, 15(6), 1112–1118.PubMedCrossRef

Benito-Leon, J., Morales, J. M., Rivera-Navarro, J., & Mitchell, A. J. (2003). A review about the impact of multiple sclerosis on health-related quality of life. Disability and Rehabilitation, 25(23), 1291–1303.PubMedCrossRef

Mitchell, A. J., Benito-Leon, J., Gonzalez, J. M., & Rivera-Navarro, J. (2005). Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of well-being. Lancet Neurology, 4(9), 556–566.PubMedCrossRef

10.

Riazi, A., Hobart, J. C., Lamping, D. L., Fitzpatrick, R., Freeman, J. A., Jenkinson, C., et al. (2003). Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles. Journal of Neurology, Neurosurgery and Psychiatry, 74(6), 710–714.PubMedCrossRef

11.

Slaughter, J. R., Slaughter, K. A., Nichols, D., Holmes, S. E., & Martens, M. P. (2001). Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 13(2), 187–196.PubMedCrossRef

12.

Schrag, A. (2006). Quality of life and depression in Parkinson’s disease. Journal of the Neurological Sciences, 248(1–2), 151–157.PubMedCrossRef

13.

Siegert, R. J., & Abernethy, D. A. (2005). Depression in multiple sclerosis: A review. Journal of Neurology, Neurosurgery and Psychiatry, 76(4), 469–475.PubMedCrossRef

14.

Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002). Depressive symptoms and severity of illness in multiple sclerosis: Epidemiological study of a large community sample. American Journal of Psychiatry, 159(11), 1862–1868.PubMedCrossRef

15.

Brown, R. F., Valpiani, E. M., Tennant, C. C., Dunn, S. M., Sharrock, M., Hodgkinson, S., et al. (2009). Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychology and Psychotherapy, 82(1), 41–56.PubMedCrossRef

16.

Coffey, C. E., & Cummings, J. L. (1994). Parkinson’s disease and parkinsonism. In C. E. Coffey & J. L. Cummings (Eds.), Textbook of geriatric neuropsychiatry (pp. 434–456). Washington DC: American Psychiatric Press.

17.

Goretti, B., Portaccio, E., Zipoli, V., Hakiki, B., Siracusa, G., Sorbi, S., et al. (2009). Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurological Sciences, 30(1), 15–20.PubMedCrossRef

18.

Montel, S., Bonnet, A.-M., & Bungener, C. (2009). Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson’s disease. Journal of Geriatric Psychiatry and Neurology, 22(2), 95–102.PubMedCrossRef

19.

Larsen, R. J. (1992). Neuroticism and selective encoding and recall of symptoms: Evidence from a combined concurrent-retrospective study. Journal of Personality and Social Psychology, 62(3), 480–488.PubMedCrossRef

20.

Kempen, G. I. J. M., Jelicic, M., & Ormel, J. (1997). Personality, chronic medical morbidity, and health-related quality of life among older persons. Health Psychology, 16(6), 539–546.PubMedCrossRef

21.

Jelicic, M., Kempen, G. I., & Passchier, J. (1998). Psychological well-being in older adults suffering from chronic headache. Headache, 38(4), 292–294.PubMedCrossRef

22.

Ranchor, A. V., Sanderman, R., & Steptoe, A. (2002). Pre-morbid predictors of psychological adjustment to cancer. Quality of Life Research, 11(2), 101–113.PubMedCrossRef

23.

Ramirez-Maestre, C., Martinez, A. E. L., & Zarazaga, R. E. (2004). Personality characteristics as differential variables of the pain experience. Journal of Behavioral Medicine, 27(2), 147–165.PubMedCrossRef

24.

Kidachi, R., Kikuchi, A., Nishizawa, Y., Hiruma, T., & Kaneko, S. (2007). Personality types and coping style in hemodialysis patients. Psychiatry and Clinical Neurosciences, 61(4), 339–347.PubMedCrossRef

25.

van Straten, A., Cuijpers, P., van Zuuren, F. J., Smits, N., & Donker, M. (2007). Personality traits and health-related quality of life in patients with mood and anxiety disorders. Quality of Life Research, 16(1), 1–8.PubMedCrossRef

26.

Dubayova, T., Nagyova, I., Havlikova, E., Rosenberger, J., Gdovinova, Z., Middel, B., et al. (2009). Neuroticism and extraversion in association with quality of life in patients with Parkinson’s disease. Quality of Life Research, 18(1), 33–42.PubMedCrossRef

27.

Pedersen, S. S., & Denollet, J. (2004). Validity of the Type D personality construct in Danish post-MI patients and healthy controls. Journal of Psychosomatic Research, 57(3), 265–572.PubMedCrossRef

28.

Denollet, J. (2005). DS-14: Standard assessment of negative affectivity, social inhibition and Type D personality. Psychosomatic Medicine, 67(1), 89–97.PubMedCrossRef

29.

Denollet, J., Sys, S. U., Stroobant, N., Rombouts, H., Gillebert, T. C., & Brutsaert, D. L. (1996). Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet, 347(8999), 417–421.PubMedCrossRef

30.

Kupper, N., & Denollet, J. (2007). Type D personality as a prognostic factor in heart disease: Assessment and mediating mechanisms. Journal of Personality Assessment, 89(3), 265–276.PubMedCrossRef

31.

Mols, F., & Denollet, J. (2009). Type D personality among nonvascular patient populations: A systematic review. General Hospital Psychiatry, 32(1), 66–72.PubMedCrossRef

32.

Dubayova, T., Nagyova, I., Havlikova, E., Rosenberger, J., Gdovinova, Z., & Middel, B., et al. (2009b). The association of Type D personality with quality of life in patients with Parkinson’s disease. Aging and Mental Health, 13(6), 905–912

33.

Bartels, H., Pedersen, S. S., van der Laan, B. F. A. M., Staal, M. J., Albers, F. W. J., & Middel, B. (2010). The impact of Type D personality on health-related quality of life in tinnitus patients is mainly mediated by anxiety and depression. Otology and Neurotology, 31(1), 11–18.PubMedCrossRef

34.

Emons, W. H. M., Meijer, R. R., & Denollet, J. (2007). Negative affectivity and social inhibition in cardiovascular disease: Evaluating Type D personality and its assessment using item response theory. Journal of Psychosomatic Research, 63(1), 27–39.PubMedCrossRef

35.

Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery and Psychiatry, 55(3), 181–184.PubMedCrossRef

36.

Folstein, M. F., Folstein, S. E., & McHough, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal Psychiatric Research, 12(3), 189–198.

37.

van Hilten, J. J., van der Zwan, A. D., Zwinderman, A. H., & Ross, R. A. (1994). Rating impairment and disability in Parkinson’s disease: Evaluation of the unified Parkinson’s disease rating scale. Movement Disorders, 9(1), 84–88.PubMedCrossRef

38.

Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452.PubMedCrossRef

39.

Zigmond, S., & Snaith, R. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.PubMedCrossRef

40.

Ware, J., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). Medical Care, 30(6), 473–483.PubMedCrossRef

41.

Ware, J. E., Snow, K. K., Kosinski, M., & Gandek, M. (1993). SF-36 health survey: Manual and interpretation guide. Boston: New England Medical Center.

42.

Newcombe, R. G., & Altman, D. G. (2000). Proportions and their differences. In D. G. Altman, D. Machin, & T. N. Bryant (Eds.), Statistic with confidence. London: BMJ Books.

43.

Horstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., & Kanovsky, P., et al. (2006a). European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson’s disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson’s disease. European Journal of Neurology, 13(11), 1170–1185

44.

Horstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., & Kanovsky, P., et al. (2006b). (2006). European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson’s disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: Late (complicated) Parkinson’s disease. European Journal of Neurology, 13(11), 1186–1202

45.

Vidal, A., Gomez-Gil, E., Sans, M., Portella, M. J., Salamero, M., Pique, J. M., et al. (2008). Health-related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality. Inflammatory Bowel Diseases, 14(7), 977–983.PubMedCrossRef

46.

Allison, P. J., Locker, D., & Feine, J. S. (1997). Quality of life: A dynamic construct. Social Science and Medicine, 45(2), 221–230.PubMedCrossRef

47.

Hyland, M. E. (1992). A reformulation of quality of life for medical science. Quality of Life Research, 1(4), 267–272.PubMedCrossRef

48.

Buenaver, L. F., Edwards, R. R., Smith, M. T., Gramling, S. E., & Haythornthwaite, J. A. (2008). Catastrophizing and pain-coping in young adults: Associations with depressive symptoms and headache pain. The Journal of Pain, 9(4), 311–319.PubMedCrossRef

49.

Wahl, A., Hanestad, B. R., Wiklund, I., & Moum, T. (1999). Coping and quality of life in patients with psoriasis. Quality of Life Research, 8(5), 427–433.PubMedCrossRef

50.

Hesselink, A. E., Penninx, B. W., Schlösser, M. A., Wijnhoven, H. A. H., van der Windt, D. A. W. M., Kriegsman, D. M. W., et al. (2004). The role of coping resources and coping style in quality of life of patients with asthma or COPD. Quality of Life Research, 13(2), 509–518.PubMedCrossRef

51.

Folkman, S., & Lazarus, R. S. (1988). Centrality and individual differences in the meaning of daily hassles. Journal of Personality, 56(4), 743–762.PubMedCrossRef

52.

Ratsep, T., Kallasmaa, T., Pulver, A., & Gross-Paju, K. (2000). Personality as a predictor of coping efforts in patients with multiple sclerosis. Multiple Sclerosis, 6(6), 397–402.PubMed

53.

Havlikova, E., Rosenberger, J., Nagyova, I., Middel, B., Dubayova, T., Gdovinova, Z., et al. (2008). Impact of fatigue on quality of life in patients with Parkinson’s disease. European Journal of Neurology, 15(5), 475–480.PubMedCrossRef

Titel: Type D, anxiety and depression in association with quality of life in patients with Parkinson’s disease and patients with multiple sclerosis
Auteurs: Tatiana Dubayova
Martina Krokavcova
Iveta Nagyova
Jaroslav Rosenberger
Zuzana Gdovinova
Berrie Middel
Johan W. Groothoff
Jitse P. van Dijk
Publicatiedatum: 01-08-2013
Uitgeverij: Springer Netherlands
Gepubliceerd in: Quality of Life Research / Uitgave 6/2013
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-012-0257-9

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2013

Longitudinal analysis of the relationship between PTSD symptom clusters, cigarette use, and physical health-related quality of life

Impact of nocturnal calf cramping on quality of sleep and health-related quality of life

Is family functioning and communication associated with health-related quality of life for Chinese- and Korean-American breast cancer survivors?

Quality of life of childbearing age women and its associated factors: an application of seemingly unrelated regression (SUR) models

Score equivalence of electronic and paper versions of the Social Difficulties Inventory (SDI-21): a randomised crossover trial in cancer patients

Interpersonal discrimination and health-related quality of life among black and white men and women in the United States